| miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4 G Zhao, B Wang, Y Liu, J Zhang, S Deng, Q Qin, K Tian, X Li, S Zhu, Y Niu, ... Molecular cancer therapeutics 12 (11), 2569-2580, 2013 | 170 | 2013 |
| MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3 G Zhao, J Zhang, Y Shi, Q Qin, Y Liu, B Wang, K Tian, S Deng, X Li, S Zhu, ... PloS one 8 (9), e73803, 2013 | 160 | 2013 |
| Effects of different resuscitation fluid on severe acute pancreatitis G Zhao, JG Zhang, HS Wu, J Tao, Q Qin, SC Deng, Y Liu, L Liu, B Wang, ... World Journal of Gastroenterology: WJG 19 (13), 2044, 2013 | 156 | 2013 |
| miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKα1 G Zhao, JG Zhang, Y Liu, Q Qin, B Wang, K Tian, L Liu, X Li, Y Niu, ... Molecular cancer therapeutics 12 (1), 83-93, 2013 | 133 | 2013 |
| Chronic pancreatitis and pancreatic cancer demonstrate active epithelial–mesenchymal transition profile, regulated by miR-217-SIRT1 pathway S Deng, S Zhu, B Wang, X Li, Y Liu, Q Qin, Q Gong, Y Niu, C Xiang, ... Cancer letters 355 (2), 184-191, 2014 | 120 | 2014 |
| Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer T Wei, X Zhang, Q Zhang, J Yang, Q Chen, J Wang, X Li, J Chen, T Ma, ... Cancer letters 452, 237-243, 2019 | 102 | 2019 |
| Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway X Li, S Deng, S Zhu, Y Jin, S Cui, J Chen, C Xiang, Q Li, C He, S Zhao, ... Oncotarget 7 (5), 6000, 2016 | 97 | 2016 |
| ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca2+/RhoA pathway S Zhu, HY Zhou, SC Deng, SJ Deng, C He, X Li, JY Chen, Y Jin, ZL Hu, ... Cell death & disease 8 (5), e2806-e2806, 2017 | 96 | 2017 |
| Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc Y Liu, X Li, S Zhu, JG Zhang, M Yang, Q Qin, SC Deng, B Wang, K Tian, ... Gene therapy 22 (9), 729-738, 2015 | 87 | 2015 |
| Monitoring tumor burden in response to FOLFIRINOX chemotherapy via profiling circulating cell-free DNA in pancreatic cancer T Wei, Q Zhang, X Li, W Su, G Li, T Ma, S Gao, J Lou, R Que, L Zheng, ... Molecular cancer therapeutics 18 (1), 196-203, 2019 | 75 | 2019 |
| MiR-548an, transcriptionally downregulated by HIF1α/HDAC1, suppresses tumorigenesis of pancreatic cancer by targeting vimentin expression S Zhu, C He, S Deng, X Li, S Cui, Z Zeng, M Liu, S Zhao, J Chen, Y Jin, ... Molecular cancer therapeutics 15 (9), 2209-2219, 2016 | 62 | 2016 |
| Development of a novel multiparametric MRI radiomic nomogram for preoperative evaluation of early recurrence in resectable pancreatic cancer TY Tang, X Li, Q Zhang, CX Guo, XZ Zhang, MY Lao, YN Shen, WB Xiao, ... Journal of Magnetic Resonance Imaging 52 (1), 231-245, 2020 | 61 | 2020 |
| Modified-FOLFIRINOX in metastatic pancreatic cancer: a prospective study in Chinese population X Li, T Ma, Q Zhang, YG Chen, CX Guo, YN Shen, PW Sun, GG Li, ... Cancer letters 406, 22-26, 2017 | 58 | 2017 |
| MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1 S Deng, X Li, Y Niu, S Zhu, Y Jin, S Deng, J Chen, Y Liu, C He, T Yin, ... Oncotarget 6 (37), 39661, 2015 | 48 | 2015 |
| MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer Y Niu, Y Jin, SC Deng, SJ Deng, S Zhu, Y Liu, X Li, C He, ML Liu, Z Zeng, ... Oncogene 37 (13), 1743-1758, 2018 | 46 | 2018 |
| The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose X Li, S Deng, M Liu, Y Jin, S Zhu, S Deng, J Chen, C He, Q Qin, C Wang, ... Cell death & disease 9 (2), 133, 2018 | 37 | 2018 |
| Association of Modified‐FOLFIRINOX‐Regimen‐Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population X Li, C Guo, Q Li, S Wei, Q Zhang, Y Chen, Y Shen, T Ma, G Li, S Gao, ... The oncologist 24 (3), 301-e93, 2019 | 32 | 2019 |
| The efficacy and toxicity of chemotherapy in the elderly with advanced pancreatic cancer X Li, D Huang, Q Zhang, C Guo, Q Fu, X Zhang, TY Tang, W Su, YW Chen, ... Pancreatology 20 (1), 95-100, 2020 | 31 | 2020 |
| High risk factors of pancreatic carcinoma SN Camara, T Yin, M Yang, X Li, Q Gong, J Zhou, G Zhao, Z Yang, ... Journal of Huazhong University of Science and Technology [Medical Sciences …, 2016 | 29 | 2016 |
| A preoperative nomogram predicts prognosis of up front resectable patients with pancreatic head cancer and suspected venous invasion YN Shen, XL Bai, G Jin, Q Zhang, JH Lu, RY Qin, RS Yu, Y Pan, Y Chen, ... Hpb 20 (11), 1034-1043, 2018 | 14 | 2018 |
